BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7957831)

  • 1. The effects of beta 2-agonists and methylxanthines on neutrophil function in vitro.
    Llewellyn-Jones CG; Stockley RA
    Eur Respir J; 1994 Aug; 7(8):1460-6. PubMed ID: 7957831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylxanthine bronchodilators potentiate multiple human neutrophil functions.
    Schmeichel CJ; Thomas LL
    J Immunol; 1987 Mar; 138(6):1896-903. PubMed ID: 2434564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of xanthine derivatives on chemotactic polypeptide-induced superoxide and enzyme release from human polymorphonuclear leucocytes.
    Hirano T; Ando M; Suzuki K; Furui H; Miyamoto K; Takagi K
    Clin Exp Pharmacol Physiol; 1993 Sep; 20(9):579-85. PubMed ID: 8222338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro.
    Llewellyn-Jones CG; Hill SL; Stockley RA
    Thorax; 1994 Mar; 49(3):207-12. PubMed ID: 8202875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN): chemotaxis, superoxide production, degranulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) receptor binding.
    Shelly J; Hoff SF
    Gen Pharmacol; 1989; 20(3):329-34. PubMed ID: 2545509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of cellular cytosolic calcium and chemotactic peptide binding by an inhibitor of neutrophil function.
    Cooper JA; Bridges TA; Kennedy JI; Culbreth R
    Am J Physiol; 1994 Jul; 267(1 Pt 1):L71-8. PubMed ID: 8048544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of some human neutrophil functions by the cyclooxygenase inhibitor ketorolac tromethamine.
    Hyers TM; Tricomi SM; Liao JJ
    J Leukoc Biol; 1992 May; 51(5):490-5. PubMed ID: 1318350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.
    Stenson WF; Mehta J; Spilberg I
    Biochem Pharmacol; 1984 Feb; 33(3):407-12. PubMed ID: 6142713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
    Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine inhibition of superoxide anion production by polymorphonuclear leukocytes.
    Yamazaki M; Matsuoka T; Yasui K; Komiyama A; Akabane T
    J Allergy Clin Immunol; 1989 May; 83(5):967-72. PubMed ID: 2541191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin does not directly affect neutrophil functions.
    Hojo M; Fujita I; Hamasaki Y; Miyazaki M; Miyazaki S
    Chest; 1994 Feb; 105(2):520-3. PubMed ID: 8306756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil chemotactic heterogeneity to N-formyl-methionyl-leucyl-phenylalanine detected by the under-agarose assay.
    Quitt M; Torres M; McGuire W; Beyer L; Coates TD
    J Lab Clin Med; 1990 Feb; 115(2):159-64. PubMed ID: 2299263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro.
    Farmer JC; Burkey TH; Kew RR; Webster RO
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):593-9. PubMed ID: 1654039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enamel matrix derivative promotes superoxide production and chemotaxis but reduces matrix metalloproteinase-8 expression by polymorphonuclear leukocytes.
    Karima MM; Van Dyke TE
    J Periodontol; 2012 Jun; 83(6):780-6. PubMed ID: 22050547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifications of the amide bond at position 3 in fMLP analogs select neutrophil functions.
    Spisani S; Breveglieri A; Fabbri E; Vertuani G; Rizzuti O; Cavicchioni G
    Pept Res; 1996; 9(6):279-82. PubMed ID: 9048420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
    Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
    Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
    Wanikiat P; Woodward DF; Armstrong RA
    Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP
    J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.